Literature DB >> 23962293

2012 trends and statistics for prescription medications in the United States: CNS therapeutics continue to hold leading positions.

Craig W Lindsley.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23962293      PMCID: PMC3750681          DOI: 10.1021/cn400127u

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


× No keyword cloud information.
  4 in total

1.  The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2010-06-16       Impact factor: 4.418

2.  The top prescription drugs of 2010 in the United States: antipsychotics show strong growth.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2011-06-15       Impact factor: 4.418

3.  The top prescription drugs of 2012 globally: biologics dominate, but small molecule CNS drugs hold on to top spots.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2013-06-19       Impact factor: 4.418

4.  The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2012-08-15       Impact factor: 4.418

  4 in total
  2 in total

Review 1.  U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations.

Authors:  Nadia Zuabi; Bhavesh Patel; Mark I Langdorf
Journal:  West J Emerg Med       Date:  2016-09-12

2.  Trends in hospital admissions due to antidepressant-related adverse drug events from 2001 to 2011 in the U.S.

Authors:  Harish S Parihar; Hongjun Yin; Jennifer L Gooch; Shari Allen; Samuel John; Jianwei Xuan
Journal:  BMC Health Serv Res       Date:  2017-01-19       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.